Estados Unidos · Plataformas y datos · Yahoo Finance

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

Publicado por Yahoo Finance · Estados Unidos hace 9 h

Solventum (NYSE: SOLV), a leader in advanced wound healing, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the combined use of…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

También te puede interesar

Haemonetics wins approval of PerQseal Elite vascular closure system

Worried About the Stock Market? This High-Yielding ETF Can Provide Stability and Generate Passive Income for Decades

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

US set to announce certification of Boeing 737 MAX 10 on Tuesday, sources say

Anthropic is AI trade's last big hope for a major IPO this year

Gartner Warns $3.5 Trillion AI Investments In Jeopardy, Reiterates Returns Don’t Justify Neocloud Buildout

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

Compartir

También te puede interesar

Haemonetics wins approval of PerQseal Elite vascular closure system

Worried About the Stock Market? This High-Yielding ETF Can Provide Stability and Generate Passive Income for Decades

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

US set to announce certification of Boeing 737 MAX 10 on Tuesday, sources say

Anthropic is AI trade's last big hope for a major IPO this year

Gartner Warns $3.5 Trillion AI Investments In Jeopardy, Reiterates Returns Don’t Justify Neocloud Buildout